[Remote] Director, Commercial Learning and Development at Gilead Sciences

California, Kentucky, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

12+ years of work experience with Bachelor's degree, out of which 10+ years related to training, sales and sales management in the biotech or pharmaceuticals industry, including 3+ years of experience in commercial training OR 10+ years of relevant experience with a Bachelor's degree
Excellent verbal, written and interpersonal skills to lead, interact with, focus, resolve conflict and drive consensus among individuals from a variety of cultures and disciplines
In-depth negotiating, influencing and consulting skills and proven project management skills

Responsibilities

Lead the design, development, and implementation of learning and development programs for China
Lead and guide new hire orientation, onboarding and knowledge/skill-based training
Design, develop and deliver employee development programs with HR Business Partners
Partner with management to define training needs through determination of knowledge gaps and needs assessment
Actively seek out new, cutting edge technology to further improve training initiatives and build efficiency
Stay abreast of and leverage Gilead best practices, and industry best practices
Support process for evaluating training effectiveness; revise training and/or training plan as needed
Identify, develop and deploy appropriate learning mechanisms to include: instructor-led, and web-based knowledge training
Drive strategic management of Learning Management Systems (LMS)
Incorporate motivating, creative, and interactive training techniques to enhance the training experience, in an effort to maximize learning and retention
Formulate management development criteria, programs and management training across all therapeutic areas
Partner with senior members of various internal departments to ensure that Learning and Development understands the strategic vision of the departments
Use broad strategic thinking to analyze the characteristics of the business environment and the challenges to developing training needs
Analyze the return on investment for training expenditure in areas of concentration, and make changes to ensure training remains relevant and valuable to the business
Partner with other regional commercial operations function leads to establish highly strategic plans and objectives

Skills

Learning and Development

Training Curriculum Design

Onboarding

Employee Development

Program Implementation

Mentorship

Leadership

HR Partnership

Needs Assessment

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free